1-20 of 21
Robert G. Maki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study

Michael J. Nathenson, Junxiao Hu, Ravin Ratan, Neeta Somaiah, Robert Hsu, Peter J. DeMaria, Heath W. Catoe, Angela Pang, Ty K. Subhawong, Behrang Amini, Kevin Sweet, Katharina Feister, Karan Malik, Jyothi Jagannathan, Marta Braschi-Amirfarzan, Jamie Sheren, Yupanqui Caldas, Cristiam Moreno Tellez, Andrew E. Rosenberg, Alexander J. Lazar, Robert G. Maki, Pasquale Benedetto, Jonathan Cohen, Jonathan C. Trent, Vinod Ravi, Shreyaskumar Patel, Breelyn A. Wilky
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18): 4092–4104.
https://doi.org/10.1158/1078-0432.CCR-21-4504
Published: 15 September 2022
View article titled, Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <em>CTNNB1</em> or <em>APC</em>: A Multi-institutional Retrospective Study
Open the PDF for Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <em>CTNNB1</em> or <em>APC</em>: A Multi-institutional Retrospective Study in another window
Includes: Supplementary data
Journal Articles

Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma

David H. Henry, Robert G. Maki
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (12): 2485–2487.
https://doi.org/10.1158/1078-0432.CCR-22-0884
Published: 13 June 2022
View article titled, Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma
Open the PDF for Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma in another window
Journal Articles

Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma

Kenneth R. Gundle, Gary B. Deutsch, Howard J. Goodman, Seth M. Pollack, Matthew J. Thompson, Jessica L. Davis, Mee-Young Lee, Daniel C. Ramirez, William Kerwin, Jessica A. Bertout, Marc O. Grenley, Kimberly H.W. Sottero, Emily Beirne, Jason Frazier, Joyoti Dey, Micah Ellison, Richard A. Klinghoffer, Robert G. Maki
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (15): 3958–3968.
https://doi.org/10.1158/1078-0432.CCR-20-0614
Published: 03 August 2020
View article titled, Multiplexed Evaluation of Microdosed Antineoplastic Agents <em>In Situ</em> in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma
Open the PDF for Multiplexed Evaluation of Microdosed Antineoplastic Agents <em>In Situ</em> in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma in another window
Includes: Supplementary data
Journal Articles

A Method to Summarize Toxicity in Cancer Randomized Clinical Trials

Mariana Carbini, Mayte Suárez-Fariñas, Robert G. Maki
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (20): 4968–4975.
https://doi.org/10.1158/1078-0432.CCR-17-3314
Published: 15 October 2018
View article titled, A Method to Summarize Toxicity in Cancer Randomized Clinical Trials
Open the PDF for A Method to Summarize Toxicity in Cancer Randomized Clinical Trials in another window
Includes: Supplementary data
Journal Articles

Abstract B32: Lymphocytes and immune checkpoint biomarker expression in sarcomas

Amanda R. Dancsok, David Thomas, Jean-Yves Blay, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2_Supplement): B32.
https://doi.org/10.1158/1557-3265.SARCOMAS17-B32
Published: 15 January 2018
View article titled, Abstract B32: Lymphocytes and immune checkpoint biomarker expression in sarcomas
Journal Articles

Correlation of KIT and PDGFRA mutation status with sunitinib activity in imatinib-resistant GIST

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless, Cristina R. Antonescu, Jonathan A. Fletcher, Christopher D. Fletcher, Xin Huang, Charles M. Baum, George D. Demetri
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): B56.
Published: 15 August 2014
View article titled, Correlation of <em>KIT</em> and <em>PDGFRA</em> mutation status with sunitinib activity in imatinib-resistant GIST
Journal Articles

New Strategies in Sarcoma Therapy: Linking Biology and Novel Agents

Katherine A. Janeway, Robert G. Maki
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 5837–5844.
https://doi.org/10.1158/1078-0432.CCR-12-0875
Published: 06 November 2012
View article titled, New Strategies in Sarcoma Therapy: Linking Biology and Novel Agents
Open the PDF for New Strategies in Sarcoma Therapy: Linking Biology and Novel Agents in another window
Journal Articles

The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial

Jason J. Luke, David R. D'Adamo, Mark A. Dickson, Mary Louise Keohan, Richard D. Carvajal, Robert G. Maki, Elisa de Stanchina, Elgilda Musi, Samuel Singer, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2638–2647.
https://doi.org/10.1158/1078-0432.CCR-11-3203
Published: 30 April 2012
View article titled, The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial
Open the PDF for The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

Mrinal M. Gounder, Robert A. Lefkowitz, Mary Louise Keohan, David R. D'Adamo, Meera Hameed, Cristina R. Antonescu, Samuel Singer, Katherine Stout, Linda Ahn, Robert G. Maki
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4082–4090.
https://doi.org/10.1158/1078-0432.CCR-10-3322
Published: 15 June 2011
View article titled, Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
Open the PDF for Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis in another window
Journal Articles

Benign Mesenchymal Stromal Cells in Human Sarcomas

Alexei Morozov, Robert J. Downey, John Healey, Andre L. Moreira, Emil Lou, Anna Franceschino, Yildirim Dogan, Roland Leung, Mark Edgar, Michael LaQuaglia, Robert G. Maki, Malcolm A.S. Moore
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (23): 5630–5640.
https://doi.org/10.1158/1078-0432.CCR-09-2886
Published: 06 December 2010
View article titled, Benign Mesenchymal Stromal Cells in Human Sarcomas
Open the PDF for Benign Mesenchymal Stromal Cells in Human Sarcomas in another window
Includes: Supplementary data
Journal Articles

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

Rashmi Chugh, J. Kyle Wathen, Shreyaskumar R. Patel, Robert G. Maki, Paul A. Meyers, Scott M. Schuetze, Dennis A. Priebat, Dafydd G. Thomas, Jon A. Jacobson, Brian L. Samuels, Robert S. Benjamin, Laurence H. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19): 4884–4891.
https://doi.org/10.1158/1078-0432.CCR-10-1177
Published: 29 September 2010
View article titled, Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial
Open the PDF for Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial in another window
Journal Articles

Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring KITAY502-3ins Mutation: An In vitro Mutagenesis Screen for Drug Resistance

Tianhua Guo, Mihai Hajdu, Narasimhan P. Agaram, Hiroko Shinoda, Darren Veach, Bayard D. Clarkson, Robert G. Maki, Samuel Singer, Ronald P. DeMatteo, Peter Besmer, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 6862–6870.
https://doi.org/10.1158/1078-0432.CCR-09-1315
Published: 11 November 2009
View article titled, Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring <em>KIT</em><sup>AY502-3ins</sup> Mutation: An <em>In vitro</em> Mutagenesis Screen for Drug Resistance
Open the PDF for Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring <em>KIT</em><sup>AY502-3ins</sup> Mutation: An <em>In vitro</em> Mutagenesis Screen for Drug Resistance in another window
Journal Articles

Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure

George D. Demetri, Michael C. Heinrich, Jonathan A. Fletcher, Christopher D.M. Fletcher, Annick D. Van den Abbeele, Christopher L. Corless, Cristina R. Antonescu, Suzanne George, Jeffrey A. Morgan, Ming Hui Chen, Carlo L. Bello, Xin Huang, Darrel P. Cohen, Charles M. Baum, Robert G. Maki
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5902–5909.
https://doi.org/10.1158/1078-0432.CCR-09-0482
Published: 14 September 2009
View article titled, Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
Open the PDF for Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure in another window
Includes: Supplementary data
Journal Articles

A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients

Robert J. Canter, Li-Xuan Qin, Robert G. Maki, Murray F. Brennan, Marc Ladanyi, Samuel Singer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8191–8197.
https://doi.org/10.1158/1078-0432.CCR-08-0843
Published: 15 December 2008
View article titled, A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients
Open the PDF for A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients in another window
Journal Articles

Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors

Narasimhan P. Agaram, Michael P. Laquaglia, Berrin Ustun, Tianhua Guo, Grace C. Wong, Nicholas D. Socci, Robert G. Maki, Ronald P. DeMatteo, Peter Besmer, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 3204–3215.
https://doi.org/10.1158/1078-0432.CCR-07-1984
Published: 15 May 2008
View article titled, Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors
Open the PDF for Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors in another window
Journal Articles

Sorafenib Inhibits the Imatinib-Resistant KITT670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor

Tianhua Guo, Narasimhan P. Agaram, Grace C. Wong, Glory Hom, David D'Adamo, Robert G. Maki, Gary K. Schwartz, Darren Veach, Bayard D. Clarkson, Samuel Singer, Ronald P. DeMatteo, Peter Besmer, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4874–4881.
https://doi.org/10.1158/1078-0432.CCR-07-0484
Published: 15 August 2007
View article titled, Sorafenib Inhibits the Imatinib-Resistant <em>KIT</em><sup><em>T670I</em></sup> Gatekeeper Mutation in Gastrointestinal Stromal Tumor
Open the PDF for Sorafenib Inhibits the Imatinib-Resistant <em>KIT</em><sup><em>T670I</em></sup> Gatekeeper Mutation in Gastrointestinal Stromal Tumor in another window
Journal Articles

Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors

Narasimhan P. Agaram, Peter Besmer, Grace C. Wong, Tianhua Guo, Nicholas D. Socci, Robert G. Maki, Diann DeSantis, Murray F. Brennan, Samuel Singer, Ronald P. DeMatteo, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (1): 170–181.
https://doi.org/10.1158/1078-0432.CCR-06-1508
Published: 02 January 2007
View article titled, Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors
Open the PDF for Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors in another window
Journal Articles

The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects

Marco Seandel, Jinru Shia, Irina Linkov, Robert G. Maki, Cristina R. Antonescu, Jakob Dupont
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6203–6204.
https://doi.org/10.1158/1078-0432.CCR-06-1292
Published: 24 October 2006
View article titled, The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects
Open the PDF for The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects in another window
Journal Articles

Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation

Cristina R. Antonescu, Peter Besmer, Tianhua Guo, Knarik Arkun, Glory Hom, Beata Koryotowski, Margaret A. Leversha, Philip D. Jeffrey, Diann Desantis, Samuel Singer, Murray F. Brennan, Robert G. Maki, Ronald P. DeMatteo
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (11): 4182–4190.
https://doi.org/10.1158/1078-0432.CCR-04-2245
Published: 01 June 2005
View article titled, Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation
Open the PDF for Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation in another window
Journal Articles

Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site

Cristina R. Antonescu, Agnes Viale, Lisa Sarran, Sylvia J. Tschernyavsky, Mithat Gonen, Neil H. Segal, Robert G. Maki, Nicholas D. Socci, Ronald P. DeMatteo, Peter Besmer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3282–3290.
https://doi.org/10.1158/1078-0432.CCR-03-0715
Published: 24 May 2004
View article titled, Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by <em>KIT</em> Genotype and Anatomic Site
Open the PDF for Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by <em>KIT</em> Genotype and Anatomic Site in another window